Ads
related to: can levodopa make parkinson's worse treatment- What Is PD Dyskinesia?
Learn About the Signs & Symptoms
of Parkinson's Dyskinesia.
- Real Patient Stories
Hear About Real Parkinson's
Dyskinesia Treatment Journeys.
- See Treatment Information
Learn About Efficacy & Safety For
a PD Off Time Treatment.
- Free Trial Options
You May Be Eligible For a Free
Trial of a Dyskinesia Treatment.
- Patient Resources
View Downloadable Resources &
Patient Assistance Programs.
- Sign Up for Updates
Get the Latest Parkinson's News &
Resources Delivered to Your Inbox.
- What Is PD Dyskinesia?
Search results
Results From The WOW.Com Content Network
Levodopa-induced dyskinesia (LID) is a form of dyskinesia associated with levodopa (l-DOPA), used to treat Parkinson's disease. It often involves hyperkinetic movements, including chorea, dystonia, and athetosis. [1] In the context of Parkinson's disease (PD), dyskinesia is often the result of long-term dopamine therapy.
In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief ...
L-DOPA, a treatment for Parkinson’s disease, may induce dyskinesia. Parkinson’s disease is a neurodegenerative disorder caused by the death of dopamine-producing neurons.
l-DOPA can be manufactured and in its pure form is sold as a drug with the INN Tooltip International Nonproprietary Name levodopa. Trade names include Sinemet, Pharmacopa, Atamet, and Stalevo. As a drug, it is used in the clinical treatment of Parkinson's disease and dopamine-responsive dystonia. l-DOPA has a counterpart with opposite chirality ...
The "gold standard" treatment for Parkinson's is levodopa, however this drug can result in differences in motor responses in as high as 50% of PD patients. One of the major consequences of sustained levodopa treatment is the "on-off" phenomenon where the therapeutic window becomes smaller.
On Thursday, the FDA approved AbbVie Inc’s (NYSE:ABBV) Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor fluctuations ...
Ads
related to: can levodopa make parkinson's worse treatment